Published in PLoS One on June 08, 2015
Maternal HIV infection influences the microbiome of HIV-uninfected infants. Sci Transl Med (2016) 0.79
The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology (2017) 0.77
Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women. AIDS Res Hum Retroviruses (2016) 0.77
Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface. Viruses (2016) 0.75
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel) (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol (2004) 7.04
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Circuitry of nuclear factor kappaB signaling. Immunol Rev (2006) 6.49
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity (2007) 6.36
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med (2007) 5.58
The role of cyclooxygenases in inflammation, cancer, and development. Oncogene (1999) 5.50
Multiple control of interleukin-8 gene expression. J Leukoc Biol (2002) 5.35
Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol (2003) 5.29
Targeting early infection to prevent HIV-1 mucosal transmission. Nature (2010) 5.05
Glycerol monolaurate prevents mucosal SIV transmission. Nature (2009) 5.02
Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70
Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol (2008) 4.25
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev (2003) 3.96
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95
The role of CXC chemokines and their receptors in cancer. Cancer Lett (2008) 3.84
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One (2008) 3.45
Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther (2004) 3.40
Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol (1994) 3.35
Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis (1990) 3.19
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis (2012) 3.06
The Toll receptor family and microbial recognition. Trends Microbiol (2000) 3.01
Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol (2006) 3.00
Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS (2003) 2.97
Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod (1997) 2.74
Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev (1991) 2.58
The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis (2001) 2.49
Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod (2005) 2.48
SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One (2007) 2.41
The inhibitory ankyrin and activator Rel proteins. Curr Opin Genet Dev (1992) 2.39
The vaginal microbiota and susceptibility to HIV. AIDS (2014) 2.24
Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol (2002) 2.22
Cyclooxygenase-2: a therapeutic target. Annu Rev Med (2002) 2.16
The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis (1991) 2.12
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS (2010) 2.03
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis (2006) 2.01
Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod (1999) 2.00
Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol (2009) 1.96
Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol (2002) 1.88
Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod (2004) 1.87
Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis (2009) 1.81
Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol (2001) 1.80
The microbiology of bacterial vaginosis. Am J Obstet Gynecol (1993) 1.79
Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med (2003) 1.78
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation (2000) 1.71
Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol (2011) 1.67
Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun (2001) 1.62
IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect (2009) 1.58
Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations. Antimicrob Agents Chemother (2007) 1.58
Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis (2010) 1.52
Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother (2004) 1.50
Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol (2008) 1.49
Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol (2007) 1.47
HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS (2010) 1.45
The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol (2009) 1.43
Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod (2005) 1.42
Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr (2004) 1.42
Innate immunity against HIV: a priority target for HIV prevention research. Retrovirology (2010) 1.41
IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses (2005) 1.39
Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. J Virol (2008) 1.36
The role of TLR activation in inflammation. J Pathol (2008) 1.35
Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol (2011) 1.33
Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol (2010) 1.33
Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7. J Immunol (2011) 1.31
Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J Leukoc Biol (2003) 1.27
Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety. Sex Transm Dis (2009) 1.25
Chromatin structure of telomere domain in human sperm. Biochem Biophys Res Commun (2000) 1.23
Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21
Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21
Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J Virol (2011) 1.19
Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy. PLoS One (2012) 1.17
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob Agents Chemother (2012) 1.16
Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities. Antiviral Res (2010) 1.15
Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis. FASEB J (2003) 1.15
Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res (2013) 1.12
Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J Gen Virol (2008) 1.12
Preclinical assessment of the proinflammatory potential of microbicide candidates. J Acquir Immune Defic Syndr (2004) 1.11
HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J Immunol (2004) 1.11
Twice-daily application of HIV microbicides alter the vaginal microbiota. MBio (2012) 1.11
Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10
Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci (1990) 1.09
Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. J Leukoc Biol (2005) 1.05
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides. Best Pract Res Clin Obstet Gynaecol (2012) 1.01
Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm (2010) 1.01
The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat Immunol (2010) 1.00
Identification and characterisation of vaginal lactobacilli from South African women. BMC Infect Dis (2013) 1.00
Safety of single daily use for one week of C31G HEC gel in women. Contraception (2002) 1.00
Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology (2010) 1.00
The role of SerpinB2 in immunity. Crit Rev Immunol (2011) 0.99
Blocking chemokine receptors. J Exp Med (1997) 0.98
HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo. AIDS (2000) 0.97
Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One (2011) 0.97
Immune responses to HIV and SIV in mucosal tissues: 'location, location, location'. Curr Opin HIV AIDS (2010) 0.96
Paternal poly (ADP-ribose) metabolism modulates retention of inheritable sperm histones and early embryonic gene expression. PLoS Genet (2014) 0.91
Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies. PLoS One (2014) 0.75